Efficacy, safety, and tolerability of etravirine with and without darunavir/ritonavir or raltegravir in treatment-experienced patients: analysis of the etravirine early access program in the United States (Q43172359)
Jump to navigation
Jump to search
scientific article published in April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, safety, and tolerability of etravirine with and without darunavir/ritonavir or raltegravir in treatment-experienced patients: analysis of the etravirine early access program in the United States |
scientific article published in April 2010 |
Statements
1 reference
Efficacy, safety, and tolerability of etravirine with and without darunavir/ritonavir or raltegravir in treatment-experienced patients: analysis of the etravirine early access program in the United States (English)
1 reference
Rodica Van Solingen-Ristea
0 references
Joseph Gathe
1 reference
William Towner
1 reference
Jacob Lalezari
1 reference
Michael G Sension
1 reference
Michael Wohlfeiler
1 reference
Jonathan S Appelbaum
1 reference
Paul Bellman
1 reference
Michael S Gottlieb
1 reference
Robert Ryan
1 reference
Steven Nijs
1 reference
Annemie Hoogstoel
1 reference
Rodica Van Solingen-Ristea
1 reference
James Witek
1 reference
1 April 2010
1 reference
1 reference
53
1 reference
5
1 reference
614-618
1 reference
Identifiers
1 reference
1 reference